Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

XAGE vs UNH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
XAGE
Longevity Health Holdings Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$7M
5Y Perf.-99.9%
UNH
UnitedHealth Group Incorporated

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$335.60B
5Y Perf.-5.4%

XAGE vs UNH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
XAGE logoXAGE
UNH logoUNH
IndustryBiotechnologyMedical - Healthcare Plans
Market Cap$7M$335.60B
Revenue (TTM)$1M$449.71B
Net Income (TTM)$-6M$12.04B
Gross Margin54.6%18.8%
Operating Margin-401.0%4.2%
Forward P/E20.2x
Total Debt$639K$78.39B
Cash & Equiv.$157K$24.36B

XAGE vs UNHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

XAGE
UNH
StockSep 21May 26Return
Longevity Health Ho… (XAGE)1000.1-99.9%
UnitedHealth Group … (UNH)10094.6-5.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: XAGE vs UNH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: UNH leads in 5 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Longevity Health Holdings Inc. is the stronger pick specifically for growth and revenue expansion. As sector peers, any of these can serve as alternatives in the same allocation.
XAGE
Longevity Health Holdings Inc.
The Growth Play

XAGE is the clearest fit if your priority is growth exposure.

  • Rev growth 139.4%, EPS growth 32.4%
  • 139.4% revenue growth vs UNH's 11.8%
Best for: growth exposure
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 25 yrs, beta 0.59, yield 2.4%
  • 220.6% 10Y total return vs XAGE's -99.9%
  • Lower volatility, beta 0.59, Low D/E 77.1%, current ratio 0.79x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthXAGE logoXAGE139.4% revenue growth vs UNH's 11.8%
Quality / MarginsUNH logoUNH2.7% margin vs XAGE's -393.6%
Stability / SafetyUNH logoUNHBeta 0.59 vs XAGE's 1.86
DividendsUNH logoUNH2.4% yield; 25-year raise streak; the other pay no meaningful dividend
Momentum (1Y)UNH logoUNH-3.2% vs XAGE's -92.6%
Efficiency (ROA)UNH logoUNH3.9% ROA vs XAGE's -173.9%, ROIC 9.2% vs -38.0%

XAGE vs UNH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

XAGELongevity Health Holdings Inc.

Segment breakdown not available.

UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B

XAGE vs UNH — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUNHLAGGINGXAGE

Income & Cash Flow (Last 12 Months)

UNH leads this category, winning 4 of 6 comparable metrics.

UNH is the larger business by revenue, generating $449.7B annually — 308591.6x XAGE's $1M. UNH is the more profitable business, keeping 2.7% of every revenue dollar as net income compared to XAGE's -3.9%. On growth, XAGE holds the edge at +19.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricXAGE logoXAGELongevity Health …UNH logoUNHUnitedHealth Grou…
RevenueTrailing 12 months$1M$449.7B
EBITDAEarnings before interest/tax-$6M$23.2B
Net IncomeAfter-tax profit-$6M$12.0B
Free Cash FlowCash after capex-$4M$19.7B
Gross MarginGross profit ÷ Revenue+54.6%+18.8%
Operating MarginEBIT ÷ Revenue-4.0%+4.2%
Net MarginNet income ÷ Revenue-3.9%+2.7%
FCF MarginFCF ÷ Revenue-2.6%+4.4%
Rev. Growth (YoY)Latest quarter vs prior year+19.8%+2.0%
EPS Growth (YoY)Latest quarter vs prior year-4.9%+0.7%
UNH leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Evenly matched — XAGE and UNH each lead in 1 of 2 comparable metrics.
MetricXAGE logoXAGELongevity Health …UNH logoUNHUnitedHealth Grou…
Market CapShares × price$7M$335.6B
Enterprise ValueMkt cap + debt − cash$7M$389.6B
Trailing P/EPrice ÷ TTM EPS-0.64x27.95x
Forward P/EPrice ÷ next-FY EPS est.20.19x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple16.70x
Price / SalesMarket cap ÷ Revenue133.03x0.75x
Price / BookPrice ÷ Book value/share3.31x
Price / FCFMarket cap ÷ FCF20.88x
Evenly matched — XAGE and UNH each lead in 1 of 2 comparable metrics.

Profitability & Efficiency

UNH leads this category, winning 6 of 8 comparable metrics.

UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-103 for XAGE. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs XAGE's 4/9, reflecting solid financial health.

MetricXAGE logoXAGELongevity Health …UNH logoUNHUnitedHealth Grou…
ROE (TTM)Return on equity-103.5%+11.5%
ROA (TTM)Return on assets-173.9%+3.9%
ROICReturn on invested capital-38.0%+9.2%
ROCEReturn on capital employed-47.5%+9.7%
Piotroski ScoreFundamental quality 0–946
Debt / EquityFinancial leverage0.77x
Net DebtTotal debt minus cash$481,854$54.0B
Cash & Equiv.Liquid assets$157,139$24.4B
Total DebtShort + long-term debt$638,993$78.4B
Interest CoverageEBIT ÷ Interest expense-293.50x4.71x
UNH leads this category, winning 6 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

UNH leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in UNH five years ago would be worth $9,743 today (with dividends reinvested), compared to $11 for XAGE. Over the past 12 months, UNH leads with a -3.2% total return vs XAGE's -92.6%. The 3-year compound annual growth rate (CAGR) favors UNH at -7.1% vs XAGE's -89.8% — a key indicator of consistent wealth creation.

MetricXAGE logoXAGELongevity Health …UNH logoUNHUnitedHealth Grou…
YTD ReturnYear-to-date+6.4%+10.6%
1-Year ReturnPast 12 months-92.6%-3.2%
3-Year ReturnCumulative with dividends-99.9%-19.9%
5-Year ReturnCumulative with dividends-99.9%-2.6%
10-Year ReturnCumulative with dividends-99.9%+220.6%
CAGR (3Y)Annualised 3-year return-89.8%-7.1%
UNH leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

UNH leads this category, winning 2 of 2 comparable metrics.

UNH is the less volatile stock with a 0.59 beta — it tends to amplify market swings less than XAGE's 1.86 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNH currently trades 93.5% from its 52-week high vs XAGE's 3.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricXAGE logoXAGELongevity Health …UNH logoUNHUnitedHealth Grou…
Beta (5Y)Sensitivity to S&P 5001.86x0.59x
52-Week HighHighest price in past year$8.27$395.52
52-Week LowLowest price in past year$0.23$234.60
% of 52W HighCurrent price vs 52-week peak+3.9%+93.5%
RSI (14)Momentum oscillator 0–10048.575.9
Avg Volume (50D)Average daily shares traded1K7.9M
UNH leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

UNH is the only dividend payer here at 2.35% yield — a key consideration for income-focused portfolios.

MetricXAGE logoXAGELongevity Health …UNH logoUNHUnitedHealth Grou…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$385.43
# AnalystsCovering analysts52
Dividend YieldAnnual dividend ÷ price+2.4%
Dividend StreakConsecutive years of raises25
Dividend / ShareAnnual DPS$8.70
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.7%
Insufficient data to determine a leader in this category.
Key Takeaway

UNH leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 1 category is tied.

Best OverallUnitedHealth Group Incorpor… (UNH)Leads 4 of 6 categories
Loading custom metrics...

XAGE vs UNH: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is XAGE or UNH a better buy right now?

UnitedHealth Group Incorporated (UNH) offers the better valuation at 27.

9x trailing P/E (20. 2x forward), making it the more compelling value choice. Analysts rate UnitedHealth Group Incorporated (UNH) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — XAGE or UNH?

Over the past 5 years, UnitedHealth Group Incorporated (UNH) delivered a total return of -2.

6%, compared to -99. 9% for Longevity Health Holdings Inc. (XAGE). Over 10 years, the gap is even starker: UNH returned +220. 6% versus XAGE's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — XAGE or UNH?

By beta (market sensitivity over 5 years), UnitedHealth Group Incorporated (UNH) is the lower-risk stock at 0.

59β versus Longevity Health Holdings Inc. 's 1. 86β — meaning XAGE is approximately 216% more volatile than UNH relative to the S&P 500.

04

Which is growing faster — XAGE or UNH?

On earnings-per-share growth, the picture is similar: Longevity Health Holdings Inc.

grew EPS 32. 4% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — XAGE or UNH?

UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.

7% net margin versus -206. 1% for Longevity Health Holdings Inc. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -99. 3% for XAGE. At the gross margin level — before operating expenses — XAGE leads at 87. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — XAGE or UNH?

In this comparison, UNH (2.

4% yield) pays a dividend. XAGE does not pay a meaningful dividend and should not be held primarily for income.

07

Is XAGE or UNH better for a retirement portfolio?

For long-horizon retirement investors, UnitedHealth Group Incorporated (UNH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

59), 2. 4% yield, +220. 6% 10Y return). Longevity Health Holdings Inc. (XAGE) carries a higher beta of 1. 86 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (UNH: +220. 6%, XAGE: -99. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between XAGE and UNH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

UNH pays a dividend while XAGE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

XAGE

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 987%
  • Gross Margin > 32%
Run This Screen
Stocks Like

UNH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform XAGE and UNH on the metrics below

Revenue Growth>
%
(XAGE: 1975.5% · UNH: 2.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.